血造干细胞采集用于状细胞病的基因治疗
Alexis Leonard1, Mitchell J Weiss
1Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Current opinion in hematology
|February 15, 2024
概括
状细胞疾病 (SCD) 的基因疗法显示出希望,但收集足够的造血干细胞 (HSC) 的挑战阻碍了治疗. 在HSC收集的改进对于更广泛的基因疗法准入至关重要.
科学领域:
- 血液学 血液学 血液学
- 基因治疗 基因治疗
- 细胞生物学 细胞生物学
背景情况:
- 状细胞疾病 (SCD) 基因疗法正在进步,最近获得了FDA的批准.
- 目前的协议依赖于自主造血干细胞 (HSC) 的ex vivo修饰.
- 骨髓损伤和氧尿素使用等SCD并发症阻碍HSC采集.
研究的目的:
- 对SCD患者的HSC采集的当前知识进行审查.
- 为了确定HSC收集安全性和有效性的潜在改进.
- 提高对状细胞疾病的基因治疗的可用性.
主要方法:
- 在SCD中审查有关HSC动员和收集的现有文献.
- 分析与当前HSC收集策略相关的挑战.
- 探索新的方法来提高HSC产量和质量.
主要成果:
- 以Plerixa为媒介的HSC动员是当前的一种策略,但有局限性.
- 患者对plerixafor的反应变化和需要多个循环增加风险.
- 不足够的HSC数量阻止了一些SCD患者的基因治疗.
结论:
- 优化HSC收集对于成功的SCD基因治疗至关重要.
- 解决动员变异性和收集效率是必不可少的.
- 增强的HSC收集策略将改善SCD的基因疗法可访问性.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


